Selected 2002 Licensing and Technology Transactions

Download IconDownload Print IconPrint

Selected 2002 Licensing and Technology Transactions

Publication

Related Documents

Related Solutions

We leverage technical knowledge, business acumen and legal experience to structure, prepare and negotiate innovative and effective technology-related agreements.
For companies in the life sciences sphere, licensing intellectual property and establishing strategic alliances are critical. WilmerHale’s experienced licensing lawyers shepherd biotech, pharmaceutical, healthcare and medical device clients of all sizes through the complex transactions that make their businesses possible, including a broad range of licensing, collaboration, strategic alliance and joint venture agreements. Our attorneys also excel at brokering manufacturing and supply agreements, contract research and development agreements, distribution and commercialization services agreements, and material transfer and confidentiality agreements. They also frequently represent life sciences clients as they license patents—often the foundations of their companies—from, and sponsor research at, leading academic institutions across the United States and Europe. Backed not only by their own experience but also the deep well of knowledge possessed by the firm’s patent, tax, antitrust and EU competition lawyers, our transactional attorneys are ready to handle even the most multifaceted matters. Our team helps clients protect their innovations, forge strategic alliances, and successfully navigate a complex, dynamic industry.
Our clients in the ever-changing and fiercely competitive hardware, software, IT and services industries depend on us to strategize and negotiate transactions that take advantage of opportunities now while protecting their innovations and preserving flexibility for the future. We structure, negotiate and draft all types of licensing, distribution, product development, joint venture and strategic alliance agreements for these clients, often drawing on the deep experience of WilmerHale’s unique capabilities in regulatory, intellectual property, corporate and tax law. We represent both mature and emerging companies with business models centered around offering software and/or professional services relating to analyzing and extracting insights from large data sets. We frequently draft and negotiate data license agreements, software-as-a-service (SaaS) agreements, website terms and other services agreements in which data is the core subject of the license. We also advise technology clients on big data issues that arise in outsourcing, joint venture and other transactional matters. Our attorneys keep a close watch on internet-related legislative and regulatory developments in the United States, the European Union and elsewhere, and leverage our up-to-the-minute knowledge to advise clients in areas such as data privacy and security, copyright infringement, and export restrictions.

In 2002, we handled hundreds of licensing, product development, distribution, joint venture, strategic alliance, collaboration and similar agreements for clients. The following are selected highlights from our 2002 transactions:

  • Airvana — Joint development and distribution agreements with major telecommunications infrastructure provider
  • American Superconductor — Distribution by Bridex Technologies of power quality and reliability solutions in the Asia-Pacific market
  • Analog Devices — Product development, supply, OEM, license and outsourcing agreements
  • Ardais — License of bioinformatics tools to Bristol-Myers Squibb
  • ASML — Industry consortia for development of next-generation lithography equipment
  • Aspect Medical Systems — Strategic alliance with Boston Scientific for the development and distribution of sedation management technology
  • BOSE — Acquisition of Chinese distribution network
  • ccbn.com — Co-marketing agreements for investor relations services and public company financial information
  • CERA — Technology and service agreements in the global energy sector
  • Cognizant Technology Solutions Corporation — IT outsourcing agreements with major financial service providers
  • deNovis — Strategic alliance with IBM to offer healthcare claims processing technology to Empire Blue Cross and Blue Shield and others
  • EMC2 — Outsourcing agreement with Accenture to provide open, platform-independent storage consulting services
  • Endeca — License of information delivery software to Barnes & Noble.com for book browsing engine
  • Eyetech Pharmaceuticals — Collaboration with Pfizer to develop and commercialize ophthalmic products for the treatment of blindness
  • Flexplay — Manufacturing, marketing and licensing relationships for next-generation DVD technology
  • Genaissance Pharmaceuticals — Collaboration agreement to apply pharmacogenomics technology to Biogen drugs in development
  • GenPath — Licenses for breeding and use of transgenic mice
  • GoAmerica Wireless Data Solutions — Strategic agreement for access to Boingo Wireless' high-speed Wi-Fi service
  • Hybridon — Collaboration agreement with Aegera Therapeutics to develop an antisense drug target to a cancer gene
  • Hydra Biosciences — Research collaborations with Abbott Laboratories
  • IAVI International AIDS Vaccine Initiative — Alliance with Imperial College, London, for world's first HIV vaccine clinical trial
  • IDEXX Laboratories — International licensing and sales agreements
  • Millennium — Long-term manufacturing agreement for bulk drug substance
  • NHL — Broadcast rights agreement for NHL Center Ice game package on cable and satellite television systems
  • NitroMed — Research collaboration and license agreement with Merck
  • Nova Biomedical — Develop agreements with Becton Dickinson for hand-held blood glucose monitors
  • Novartis — License to Schering-Plough of exclusive U.S. distribution and marketing rights to Foradil Aerolizer
  • Ocean Spray — Strategic operations alliance with Nestlé
  • Penwest — Joint development with Endo Pharmaceuticals of an extended-release oral form of oxymorphone
  • Phylogix Inc — Bioprocessing alliance with Large Scale Biology Corporation to manufacture therapeutic protein
  • Public Interest Registry — Creation of the new .org domain name registry and related agreements with ICANN, Afilias and VeriSign
  • TargetRx — Marketing information engagements by major pharmaceutical companies
  • The Dun & Bradstreet Corporation — Strategic alliance with Fair, Isaac to develop and offer small business credit and risk management solutions
  • The Medicines Company — Development and commercialization agreement with AstraZeneca for clevidipine
  • Thermo Electron Corporation — International distribution arrangements
  • Transkaryotic Therapies — Patent license from Cell Genesys
  • Triple G — Provision of laboratory information systems and services to major hospital networks
  • SI2Silicon Integration Initiative, Inc. — Development of EDA data model using Cadence Design Systems source code
  • Starent Networks — Multi-year contract to supply key data network elements for China Unicom wireless network
  • Syngenta — Collaborative biotechnology research platform with Diversa for new plant science applications
  • WaterCove Networks — OEM agreement to incorporate Ulticom's carrier-grade signaling capabilities into wireless data services

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.

I Accept Cancel